Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Assertio Holdings, Inc. Director's Dealing 2020

May 22, 2020

34279_dirs_2020-05-21_4bf57194-a8ce-4b36-a41b-e817e9c7639f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Assertio Holdings, Inc. (ASRT)
CIK: 0001808665
Period of Report: 2020-05-19

Reporting Person: Peisert Daniel A. (EVP and CFO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-05-19 Stock Options $0.8 A 200000 Acquired 2030-05-19 Common Stock (200000.0) Direct
2020-05-19 Restricted Stock Units $ A 100000 Acquired Common Stock (100000.0) Direct

Footnotes

F1: As a result of a holding company reorganization effective May 19, 2020, Assertio Holdings, Inc., is the successor issuer to Assertio Therapeutics, Inc., pursuant to 12g-3(a) of the Exchange Act.

F2: These options vest in full on May 19, 2021.

F3: Each restricted stock unit represents a contingent right to receive one share of the registrant's common stock.

F4: These restricted stock units are scheduled to vest in full on May 19, 2021.